HCV and COVID-19: Impact of Overlapping Pandemics

Review data on the clinical interplay of liver disease and COVID-19 and the impact of COVID-19 on access to HCV care and treatment
Ricardo Franco, MD
Stacey Trooskin, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.26 MB
Released: October 7, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AbbVie

Related Content

In this CCO commentary, Drs. Chinazo Cunningham and Tiffany Lu outline how HCV and HIV clinicians can integrate OUD care into their clinical practice

Chinazo Cunningham, MD, MS person default Tiffany Lu, MD, MS Released: October 22, 2020

Gain experts insight with this CCO commentary on key hepatitis C elimination studies presented at the Digital International Liver Conference 2020

Nancy Reau, MD Released: October 2, 2020

Downloadable slides from CCO expert, Dr. Alain H. Litwin, on integrating HCV and HIV prevention and care strategies into addiction care settings

Alain H. Litwin, MD Released: September 18, 2020

Dr. Stefan Zeuzem discusses new viral hepatitis data reported at the 2020 Digital International Liver Congress, in the CCO Infectious Disease podcast

Stefan Zeuzem, MD Released: September 14, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue